一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> ACS Applied Energy Materials >>article
ACS Applied Energy Materials

ACS Applied Energy Materials

IF: 5.4
Download PDF

Current insights on clinical efficacy of roflumilast for treatment of COPD, asthma and ACOS.

Published:1 November 2020 DOI: 10.1016/j.intimp.2020.106906 PMID: 33182057
Shradha Bodkhe, Mayuri Nikam, Atul P Sherje, Tabassum Khan, Vasanti Suvarna, Kavit Patel

Abstract

Phosphodiesterase-4 inhibitors (PDE4) are of great interest for the treatment of airway inflammatory diseases due to its broad anti-inflammatory effects. Roflumilast is a selective PDE4 inhibitor that inhibits pulmonary and systemic inflammation and rallies symptoms in airway diseases. Asthma and COPD are common chronic airway inflammatory diseases having incompletely illustrious pathophysiology and clinical manifestations. Recently, the condition called Asthma- COPD Overlap (ACO) has been evolved having the overlapping symptoms of both diseases. The newly discovered PDE4 inhibitor, roflumilast has exposed its potential in the treatment of Asthma, COPD and ACOS. Its mechanism of action in airway inflammatory diseases are said to be exerts by elevating intracellular cAMP and shows its anti-inflammatory action. Roflumilast, a promising therapeutic approach in inflammatory airway diseases, has many significant outcomes. In this review, we have provided various promising clinical evidences of roflumilast in COPD and asthma. However, there is no published clinical evidence to date for the role of roflumilast in ACOS. Nevertheless, there are therapeutic mechanisms that provide a reference for clinical application for ACOS.

Substances (2)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Roflumilast 162401-32-3 C17H14Cl2F2N2O3 524 suppliers $5.00-$1789.00
PDE4 antibody 10 suppliers Inquiry

Similar articles

IF:5.4

Pharmacological mechanism of roflumilast in the treatment of asthma-COPD overlap.

ACS Applied Energy Materials Xiaoli Zhang, Yuqing Chen,etc Published: 1 August 2018
IF:2.1

Efficacy and safety profile of roflumilast in a real-world experience.

Journal of thoracic disease Aykut Cilli, Halid Bal,etc Published: 1 April 2019
IF:4.3

A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.

ACS Applied Electronic Materials Noemi Lois, Evie Gardner,etc Published: 14 July 2020
舒兰市| 玉环县| 岑巩县| 兴宁市| 霍邱县| 丘北县| 肥城市| 高雄市| 莱芜市| 普定县| 扬中市| 蓬安县| 葵青区| 宝应县| 昌邑市| 安仁县| 河源市| 从化市| 仁化县| 十堰市| 成都市| 江达县| 墨竹工卡县| 陇南市| 昌吉市| 阿勒泰市| 肇州县| 乾安县| 图木舒克市| 土默特右旗| 蒙阴县| 临海市| 和田县| 舞钢市| 顺平县| 昭觉县| 浑源县| 余江县| 焉耆| 东宁县| 丰都县|